A Multicenter Single-Arm Phase II Trial Evaluating the Safety and Efficacy of Panitumumab and Irinotecan in Patients with NeoRAS Wild-Type Metastatic Colorectal Cancer (C-PROWESS Trial) EMJ
Celcuity Announces FDA Approval Of Revtorpyk™ (Gedatolisib) For The Treatment Of Hr+/Her2-, Pik3ca Wild-Type Locally Advanced Or Metastatic Breast Cancer TradingView